Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) is one of the worst-performing stocks on Tuesday. Vertex Pharmaceuticals nosedived ...

In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $484.01, marking a +0.11% move from the previous day. This change outpaced the S&P 500's 4.84% loss on the day. At the same ...

Vertex Pharmaceuticals (VRTX) closed at $281.71 in the latest trading session, marking a -1.26% move from the prior day. This change was narrower than the S&P 500's 1.48% loss on the day ...

The most recent trading session ended with Vertex Pharmaceuticals (VRTX) standing at $416.96, reflecting a -1.72% shift from the previouse trading day's closing. The stock's performance was behind ...

Vertex Pharmaceuticals stock (NASDAQ: VRTX) is trending higher after the U.S. FDA approved Journavx – an oral non-opioid pain medication. This is a big win for Vertex, given that Journavx can ...

Longer term, VRTX has climbed 20.7% on a YTD basis, surpassing IYH’s 6.4% gain. Additionally, shares of Vertex Pharmaceuticals have surged 14.7% over the past 52 weeks, while the IYH has ...

Vertex Pharmaceuticals (VRTX) closed at $469.29 in the latest trading session, marking a -0.99% move from the prior day. The stock's change was less than the S&P 500's daily loss of 0.3% ...

The most recent trading session ended with Vertex Pharmaceuticals (VRTX) standing at $367.66, reflecting a +1.6% shift from the previouse trading day's closing. The stock's change was more than ...

Vertex Pharmaceuticals (VRTX) closed at $295.23 in the latest trading session, marking a -1.14% move from the prior day. This change was narrower than the S&P 500's daily loss of 2.8%. At the same ...

In the latest market close, Vertex Pharmaceuticals (VRTX) reached $420.48, with a +0.59% movement compared to the previous day. The stock outperformed the S&P 500, which registered a daily loss of ...